Kiadis Pharma Announces Investor Events for September 2019
August 19, 2019 11:45 ET
|
Kiadis Pharma N.V.
Company announces Notice of Results for the six months ended June 30, 2019 Amsterdam, The Netherlands, August 19, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam...
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
August 15, 2019 13:30 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is preparing to...
Wuhan General Group Appoints Distinguished Scientist Dr. Hyder A. Khoja as Chief Scientific Officer
August 15, 2019 08:34 ET
|
Wuhan General Group (China), Inc.
Barcelona, Spain, Aug. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Wuhan General Group, Inc. (OTC PINK: WUHN) (the "Company" and "Wuhan"), is positioning itself to become a major player in the...
Companies Adopt Rooney Rule, Add Women and Minorities to Boards as Midwest Investors Diversity Initiative Gains Momentum
August 13, 2019 08:00 ET
|
UAW Retiree Medical Benefits Trust
Detroit, Michigan, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Investors from Illinois, Michigan, Minnesota, Ohio and Wisconsin with more than $750 billion in assets urge Midwest companies to adopt diverse...
CURE Pharmaceutical Expands Board with Two Women Directors
August 07, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of two directors to its Board,...
The Alliance for Regenerative Medicine Releases Q2 2019 Global Sector Report, Highlighting Industry Trends and Metrics
August 01, 2019 10:01 ET
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly global sector report, offering an...
Voyageur Closes First Tranche of Non-Brokered Private Placement
July 29, 2019 15:02 ET
|
Voyageur Minerals Ltd
NOT FOR DISTRIBUTION IN THE UNITED STATES CALGARY, Alberta, July 29, 2019 (GLOBE NEWSWIRE) -- Voyageur Minerals Ltd. (TSXV-VM) (the “Company” or “Voyageur”) is pleased to announce the closing on...
Amarillo Biosciences and Xiamen Weiyang Pharmaceutical Sign Term Sheet Outlining China Licensing and Royalty Agreement
July 29, 2019 10:54 ET
|
Amarillo Biosciences, Inc.
Amarillo, TX, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarillo Biosciences, Inc. (“ABI” or the “Company”), (OTCBB: AMAR), a diversified healthcare company, today announced that it has...
Zicix Corporation (ZICX: OTCMKTS US) Introduces Their Grow Business Division Including CBD Branded Products and Hemp Farming in Commercial Hemp Business
July 24, 2019 09:45 ET
|
Zicix Corporation
San Antonio, TX, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zicix Corporation is updating shareholders that in addition to its Zicix Smartphone Coupon Redemption Application which will...
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin in Ulcerative Proctitis/Ulcerative Proctosigmoiditis
July 22, 2019 09:30 ET
|
Innovation Pharmaceuticals, Inc.
BEVERLY, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has...